Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM. Barcellini L, et al. Among authors: borroni e. Eur Respir J. 2016 Nov;48(5):1411-1419. doi: 10.1183/13993003.00510-2016. Epub 2016 Jul 7. Eur Respir J. 2016. PMID: 27390280 Free article.
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.
Goletti D, Carrara S, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E. Goletti D, et al. Among authors: borroni e. PLoS One. 2008;3(10):e3417. doi: 10.1371/journal.pone.0003417. Epub 2008 Oct 15. PLoS One. 2008. PMID: 18923709 Free PMC article. Clinical Trial.
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy.
Fattorini L, Migliori GB, Cassone A, Mustazzolu A, Piccaro G, Filippini P, Cirillo DM, Borroni E; Italian Multicentre Study on Resistance to Antituberculosis Drugs Group. Fattorini L, et al. Among authors: borroni e. Eur Respir J. 2012 May;39(5):1263-6. doi: 10.1183/09031936.00129011. Eur Respir J. 2012. PMID: 22547735 Free article. No abstract available.
Drug-resistant tuberculosis among foreign-born persons in Italy.
Fattorini L, Mustazzolu A, Piccaro G, Pardini M, Filippini P, Giannoni F, Migliori GB, Sotgiu G, Borroni E, Cirillo DM; Italian Multicentre Study on Resistance to Antituberculosis Drugs Group. Fattorini L, et al. Among authors: borroni e. Eur Respir J. 2012 Aug;40(2):497-500. doi: 10.1183/09031936.00021012. Eur Respir J. 2012. PMID: 22855470 Free article. No abstract available.
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET. Sester M, et al. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC. Am J Respir Crit Care Med. 2014. PMID: 25303140 Clinical Trial.
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM. Tagliani E, et al. Among authors: borroni e. J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15. J Clin Microbiol. 2015. PMID: 26179309 Free PMC article.
244 results